Genome-Wide Association Scan for Survival on Dialysis in African-Americans with Type 2 Diabetes

Background: African-Americans (AAs) with diabetes have high incidence rates of end-stage renal disease (ESRD) with associated high mortality. Genetic factors modulating the risk of mortality on dialysis are poorly understood. Methods: A genome-wide association study was performed in 610 AAs with type 2 diabetes (T2D) and ESRD on dialysis, using the Affymetrix 6.0 platform (868,155 SNPs). Time to death was assessed using Cox proportional hazards model adjusting for ancestry and other confounding variables. Cases were censored at kidney transplant or (if living) at study conclusion. Results: Mean follow-up was 5.4 ± 3.5 years; 434 deaths were recorded. Five SNPs were associated with time to death at p < 1.00 × 10–6: rs2681019 (HR = 2.58, PREC = 8.00 × 10–8), rs815815 in CALM2 (HR = 1.51, PADD = 6.50 × 10–7), rs926392 (HR = 2.37, PREC = 4.80 × 10–7), and rs926391 (HR = 2.30, PREC = 7.30 × 10–7) near DHX35, and rs11128347 in PDZRN3 (HR = 0.57, PADD = 6.00 × 10–7). Other SNPs had nominal associations with time to death (p < 1.00 × 10–5). Conclusion: Genetic variation may modify the risk of death on dialysis. SNPs in proximity to genes regulating vascular extracellular matrix, cardiac ventricular repolarization, and smoking cessation are associated with dialysis survival in AAs with T2D. These results warrant replication in other cohorts and races.

[1]  Jasmin Divers,et al.  A genome-wide association study for diabetic nephropathy genes in African Americans. , 2011, Kidney international.

[2]  G. Uhl,et al.  Genome-Wide Association for Smoking Cessation Success in a Trial of Precessation Nicotine Replacement , 2010, Molecular medicine.

[3]  C. Winkler,et al.  Association of Trypanolytic ApoL1 Variants with Kidney Disease in African Americans , 2010, Science.

[4]  D. Ramji,et al.  ADAMTS proteases: key roles in atherosclerosis? , 2010, Journal of Molecular Medicine.

[5]  M. Goumans,et al.  Hyaluronic acid metabolism is increased in unstable plaques , 2010, European journal of clinical investigation.

[6]  A. Hofman,et al.  Genomic Variation Associated With Mortality Among Adults of European and African Ancestry With Heart Failure: The Cohorts for Heart and Aging Research in Genomic Epidemiology Consortium , 2010, Circulation. Cardiovascular genetics.

[7]  Eric Boerwinkle,et al.  Association of Genome-Wide Variation With the Risk of Incident Heart Failure in Adults of European and African Ancestry: A Prospective Meta-Analysis From the Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Consortium , 2010, Circulation. Cardiovascular genetics.

[8]  Igor A. Levandovskiy,et al.  Computational and QSAR study of the alkylnaphthyl ketones adsorption on silver-ion stationary phase , 2010, Journal of molecular modeling.

[9]  J. Bressler,et al.  Genetic variants identified in a European genome-wide association study that were found to predict incident coronary heart disease in the atherosclerosis risk in communities study. , 2010, American journal of epidemiology.

[10]  M. Wolf,et al.  Klotho Variants and Chronic Hemodialysis Mortality , 2009, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[11]  J. Carrero,et al.  CCR5 deletion protects against inflammation-associated mortality in dialysis patients. , 2009, Journal of the American Society of Nephrology : JASN.

[12]  Caryn Lerman,et al.  Molecular genetics of successful smoking cessation: convergent genome-wide association study results. , 2008, Archives of general psychiatry.

[13]  D. Bers,et al.  Calmodulin and Ca2+/calmodulin kinases in the heart - physiology and pathophysiology. , 2007, Cardiovascular research.

[14]  D. Bers,et al.  Calmodulin and Ca 2+ /calmodulin kinases in the heart — Physiology and pathophysiology , 2007 .

[15]  T. Gondo,et al.  PDZRN3 (LNX3, SEMCAP3) is required for the differentiation of C2C12 myoblasts into myotubes , 2006, Journal of Cell Science.

[16]  J. Allison,et al.  Survival advantage of black patients with kidney disease after acute myocardial infarction. , 2006, Clinical journal of the American Society of Nephrology : CJASN.

[17]  C. Zoccali,et al.  Predictors of cardiovascular death in ESRD. , 2005, Seminars in nephrology.

[18]  P. Stenvinkel,et al.  Low fetuin-A levels are associated with cardiovascular death: Impact of variations in the gene encoding fetuin. , 2005, Kidney international.

[19]  N. Risch,et al.  Estimation of individual admixture: Analytical and study design considerations , 2005, Genetic epidemiology.

[20]  C. Langefeld,et al.  A genome scan for diabetic nephropathy in African Americans. , 2004, Kidney international.

[21]  R. Wolfe,et al.  Association of comorbid conditions and mortality in hemodialysis patients in Europe, Japan, and the United States: the Dialysis Outcomes and Practice Patterns Study (DOPPS). , 2003, Journal of the American Society of Nephrology : JASN.

[22]  C. Mummery,et al.  Receptor protein tyrosine phosphatase mu expression as a marker for endothelial cell heterogeneity; analysis of RPTPmu gene expression using LacZ knock-in mice. , 2003, The International journal of developmental biology.

[23]  Pak Chung Sham,et al.  Genetic Power Calculator: design of linkage and association genetic mapping studies of complex traits , 2003, Bioinform..

[24]  A. Jha,et al.  Racial differences in mortality among men hospitalized in the Veterans Affairs health care system. , 2001, JAMA.

[25]  M. Rocco,et al.  Racial/ethnic analysis of selected intermediate outcomes for hemodialysis patients: results from the 1997 ESRD Core Indicators Project. , 1999, American journal of kidney diseases : the official journal of the National Kidney Foundation.